Liraglutide clinical trials: 262 trials
Page 2 of 6
- Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity
NCT04074161 · Phase 3 · Completed
Posted results
- Cardiovascular Effects of GLP-1 Receptor Activation
NCT03101930 · Phase 4 · Completed
Posted results
- LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
NCT02964247 · Phase 3 · Completed
Posted results
- Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
NCT02963935 · Phase 3 · Completed
Posted results
- Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
NCT01620489 · Phase 3 · Completed
Posted results
- Liraglutide Hospital Discharge Trial
NCT01919489 · Phase 4 · Completed
Posted results
- RISE Adult Medication Study
NCT01779362 · Phase 3 · Completed
Posted results
- Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes
NCT00395746 · Phase 3 · Completed
Posted results
- Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
NCT01572740 · Phase 3 · Completed
Posted results
- Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
NCT02918279 · Phase 3 · Completed
Posted results
- Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
NCT02060383 · Phase 4 · Completed
Posted results
- Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
NCT03018028 · Phase 3 · Completed
Posted results
- Impact of Liraglutide 3.0 on Body Fat Distribution
NCT03038620 · Phase 4 · Completed
Posted results
- A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
NCT02911948 · Phase 3 · Completed
Posted results
- Individualized Obesity Pharmacotherapy
NCT03374956 · Phase 3 · Completed
Posted results
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
NCT02072096 · Phase 4 · Terminated
Posted results
- The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
NCT01966978 · Phase 4 · Completed
Posted results
- Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
NCT01234649 · Phase 3 · Completed
Posted results
- Lifestyle Modification and Liraglutide
NCT02911818 · Phase 4 · Completed
Posted results
- IDegLira HIGH Trial
NCT03737240 · Phase 3 · Completed
Posted results
- Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
NCT01541215 · Phase 3 · Completed
Posted results
- Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
NCT03048578 · Phase 4 · Completed
Posted results
- Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
NCT02014740 · Phase 4 · Completed
Posted results
- Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
NCT03480022 · Phase 3 · Completed
Posted results
- Liraglutide In Overweight Patients With Type 1 Diabetes
NCT01753362 · Phase 3 · Completed
Posted results
- Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus
NCT02889510 · Phase 3 · Completed
Posted results
- EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
NCT04531176 · Phase 4 · Terminated
Posted results
- Liraglutide in the Treatment of Type 1 Diabetes Mellitus
NCT01722266 · Phase 3 · Completed
Posted results
- LIPT - Liraglutide in Polycystic Ovary Syndrome
NCT02073929 · Phase 4 · Completed
Posted results
- Adding Liraglutide to High Dose Insulin: Breaking the Cycle
NCT01505673 · Phase 4 · Completed
Posted results
- The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
NCT03151005 · Phase 4 · Completed
Posted results
- Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
NCT06533527 · Phase 4 · Completed
Posted results
- Liraglutide in Type 1 Diabetes
NCT01722240 · Phase 3 · Completed
Posted results
- Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.
NCT01784965 · Phase 3 · Completed
Posted results
- Liraglutide and Peripheral Artery Disease
NCT04881110 · Phase 4 · Completed
Posted results
- Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
NCT02527200 · Phase 3 · Completed
Posted results
- The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
NCT00620282 · Phase 3 · Completed
Posted results
- Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
NCT03115424 · Phase 3 · Completed
Posted results
- Liraglutide Effects on Epicardial Fat Inflammatory Genes
NCT03260881 · Phase 4 · Completed
Posted results
- Binge Eating Liraglutide Intervention
NCT03279731 · Phase 3 · Terminated
Posted results
- A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification
NCT02100475 · Phase 3 · Completed
Posted results
- Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI
NCT01562678 · Phase 4 · Completed
Posted results
- Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
NCT02518945 · Phase 3 · Completed
Posted results
- The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis
NCT02765399 · Phase 4 · Completed
Posted results
- The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
NCT01847313 · Phase 3 · Completed
Posted results
- Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
NCT01937598 · Phase 3 · Completed
Posted results
- 52 Week Trial of Liraglutide in Type 1 Diabetes
NCT01787916 · Phase 4 · Completed
Posted results
- To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
NCT02299388 · Phase 4 · Completed
Posted results
- Liraglutide in Adolescents With Type 1 Diabetes
NCT02516657 · Phase 3 · Completed
Posted results
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
NCT00318422 · Phase 3 · Completed
Linked paper with results